Pregabalin 75 Mg + Duloxetine 20 Mg Capsules (Delayed Release) – CYMENKA PG 75/20

Pregabalin 75 Mg + Duloxetine 20 Mg Capsules (Delayed Release) – Dual Action for Effective Pain and Mood Management.

CYMENKA PG 75/20: The Dual combination of Pregabalin-75mg + Duloxetine 20mg Caps (Delayed Release) is a gastro-resistant pellet which ensures that the active ingredients are protected from stomach acid, allowing them to be absorbed in the intestines for maximum efficacy and patient tolerance, and Pregabalin and Duloxetine in gastro-resistant pellet form. Pregabalin works by inhibiting the release of excitatory neurotransmitters to reduce neuropathic pain. At the same time, Duloxetine helps in the regulation of serotonin and norepinephrine levels in the brain, addressing both pain and mood disorders like depression and anxiety.

Recommended By Specialists:
Neurologists: It is mainly used to prefer to treat the disease associated with treatment for peripheral neuropathy, sciatica, post-herpetic neuralgia, diabetic neuropathy, and nerve-related chronic pain
Orthopedic Specialists: It is mainly used to prefer to treat the disease associated with chronic back pain, spondylosis with nerve involvement, and radiculopathy
General Physicians: It should be preferred for long-term management of chronic pain, especially in geriatric patients

Key Benefits of Pregabalin-75mg + Duloxetine 20mg Caps (Delayed Release) – CYMENKA PG 75/20
Dual Mechanism of Action: It combines Pregabalin, a neuropathic pain reliever, with Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI) that helps alleviate pain and mood disorders simultaneously.
Gastro-resistant pellets protect the active ingredients from stomach acid, ensuring optimal absorption and preventing irritation. They also offer better efficacy and patient comfort.
Comprehensive Treatment: Effectively addresses both neuropathic pain and associated mood disorders such as depression and anxiety, making it ideal for patients with coexisting conditions

INDICATIONS:
Neuropathic Pain
Generalized Anxiety Disorder (GAD)
Major Depressive Disorder (MDD)
Fibromyalgia
Chronic Musculoskeletal Pain